IFN-I promotes T-cell–independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD

2.

Kavanagh

PL

,

Fasipe

TA

,

Wun

T

.

Sickle cell disease: a review

.

JAMA

.

2022

;

328

(

1

):

57

-

68

.

3.

White

SL

,

Hart

K

,

Kohn

DB

.

Diverse approaches to gene therapy of sickle cell disease

.

Annu Rev Med

.

2023

;

74

(

1

):

473

-

487

.

4.

Salinas Cisneros

G

,

Thein

SL

.

Research in sickle cell disease: from bedside to bench to bedside

.

Hemasphere

.

2021

;

5

(

6

):

e584

.

5.

Nader

E

,

Romana

M

,

Connes

P

.

The red blood cell-inflammation vicious circle in sickle cell disease

.

Front Immunol

.

2020

;

11

:

454

.

6.

Liu

Y

,

Pal

M

,

Bao

W

, et al.

Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease

.

Blood

.

2021

;

138

(

13

):

1162

-

1171

.

7.

Madany

E

,

Lee

J

,

Halprin

C

, et al.

Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease

.

EJHaem

.

2021

;

2

(

4

):

700

-

710

.

8.

Lee

JY

,

Madany

E

,

El Kadi

N

, et al.

Type 1 interferon gene signature promotes RBC alloimmunization in a lupus mouse model

.

Front Immunol

.

2020

;

11

:

584254

.

9.

Beckman

JD

,

Sparkenbaugh

EM

.

The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease

.

Curr Opin Hematol

.

2023

;

30

(

5

):

153

-

158

.

10.

Allali

S

,

Rignault-Bricard

R

,

de Montalembert

M

, et al.

HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease

.

Blood

.

2022

;

140

(

18

):

1972

-

1982

.

11.

Han

J

,

Saraf

SL

,

Gordeuk

VR

.

Vaccination in sickle cell disease: immunocompromised or immunocompetent?

.

Br J Haematol

.

2023

;

202

(

5

):

916

-

918

.

12.

Pecker

LH

,

Lanzkron

S

.

Sickle cell disease

.

Ann Intern Med

.

2021

;

174

(

1

):

ITC1

-

ITC16

.

13.

Sobota

A

,

Sabharwal

V

,

Fonebi

G

,

Steinberg

M

.

How we prevent and manage infection in sickle cell disease

.

Br J Haematol

.

2015

;

170

(

6

):

757

-

767

.

14.

Ochocinski

D

,

Dalal

M

,

Black

LV

, et al.

Life-threatening infectious complications in sickle cell disease: a concise narrative review

.

Front Pediatr

.

2020

;

8

:

38

.

15.

Tampaki

A

,

Gavriilaki

E

,

Varelas

C

,

Anagnostopoulos

A

,

Vlachaki

E

.

Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing

.

Blood Rev

.

2021

;

48

:

100805

.

16.

Nakahara

H

,

Cheedarla

N

,

Verkerke

HP

, et al.

Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease

.

Br J Haematol

.

2023

;

202

(

5

):

937

-

941

.

17.

Green

NS

,

Van Doren

L

,

Licursi

M

, et al.

Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: a single-site analysis in New York City

.

Br J Haematol

.

2022

;

198

(

4

):

680

-

683

.

18.

Goldblatt

D

,

Johnson

M

,

Evans

J

.

Antibody responses to haemophilus influenzae type b conjugate vaccine in sickle cell disease

.

Arch Dis Child

.

1996

;

75

(

2

):

159

-

161

.

19.

Yazdanbakhsh

K

,

Ware

RE

,

Noizat-Pirenne

F

.

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management

.

Blood

.

2012

;

120

(

3

):

528

-

537

.

20.

Holtzclaw

JD

,

Jack

D

,

Aguayo

SM

,

Eckman

JR

,

Roman

J

,

Hsu

LL

.

Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice

.

Am J Respir Crit Care Med

.

2004

;

169

(

6

):

687

-

695

.

21.

Haniuda

K

,

Nojima

T

,

Ohyama

K

,

Kitamura

D

.

Tolerance induction of IgG+ memory B cells by T cell-independent type II antigens

.

J Immunol

.

2011

;

186

(

10

):

5620

-

5628

.

22.

Vinuesa

CG

,

Chang

PP

.

Innate B cell helpers reveal novel types of antibody responses

.

Nat Immunol

.

2013

;

14

(

2

):

119

-

126

.

23.

Haas

KM

.

Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens

.

J Immunol

.

2011

;

187

(

10

):

5183

-

5195

.

24.

Mond

JJ

,

Lees

A

,

Snapper

CM

.

T cell-independent antigens type 2

.

Annu Rev Immunol

.

1995

;

13

(

1

):

655

-

692

.

25.

Allman

D

,

Pillai

S

.

Peripheral B cell subsets

.

Curr Opin Immunol

.

2008

;

20

(

2

):

149

-

157

.

26.

Jin

W

,

Luo

Z

,

Yang

H

.

Peripheral B cell subsets in autoimmune diseases: clinical implications and effects of B cell-targeted therapies

.

J Immunol Res

.

2020

;

2020

:

9518137

.

27.

Hayakawa

K

,

Hardy

RR

,

Herzenberg

LA

,

Herzenberg

LA

.

Progenitors for Ly-1 B cells are distinct from progenitors for other B cells

.

J Exp Med

.

1985

;

161

(

6

):

1554

-

1568

.

28.

Smith

FL

,

Baumgarth

N

.

B-1 cell responses to infections

.

Curr Opin Immunol

.

2019

;

57

:

23

-

31

.

29.

Baumgarth

N

,

Herman

OC

,

Jager

GC

,

Brown

L

,

Herzenberg

LA

,

Herzenberg

LA

.

Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system

.

Proc Natl Acad Sci U S A

.

1999

;

96

(

5

):

2250

-

2255

.

30.

Haas

KM

,

Poe

JC

,

Steeber

DA

,

Tedder

TF

.

B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae

.

Immunity

.

2005

;

23

(

1

):

7

-

18

.

31.

Baumgarth

N

.

B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production

.

Front Immunol

.

2016

;

7

:

324

.

32.

Daly

CA

,

Spurrier

MA

,

Jennings-Gee

JE

,

Haas

KM

.

B cell subsets differentially contribute to the T cell-independent memory pool

.

J Immunol

.

2020

;

205

(

9

):

2362

-

2374

.

33.

Alugupalli

KR

.

A distinct role for B1b lymphocytes in T cell-independent immunity

.

Curr Top Microbiol Immunol

.

2008

;

319

:

105

-

130

.

34.

Casali

P

,

Burastero

SE

,

Nakamura

M

,

Inghirami

G

,

Notkins

AL

.

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

.

Science

.

1987

;

236

(

4797

):

77

-

81

.

35.

Zhong

X

,

Lau

S

,

Bai

C

, et al.

A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice

.

Arthritis Rheum

.

2009

;

60

(

12

):

3734

-

3743

.

36.

Xu

Z

,

Morel

L

.

Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model

.

Ann N Y Acad Sci

.

2015

;

1362

(

1

):

215

-

223

.

37.

Griffin

DO

,

Rothstein

TL

.

A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus

.

J Exp Med

.

2011

;

208

(

13

):

2591

-

2598

.

38.

Murakami

M

,

Tsubata

T

,

Okamoto

M

, et al.

Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice

.

Nature

.

1992

;

357

(

6373

):

77

-

80

.

39.

Murakami

M

,

Honjo

T

.

Anti-red blood cell autoantibody transgenic mice: murine model of autoimmune hemolytic anemia

.

Semin Immunol

.

1996

;

8

(

1

):

3

-

9

.

40.

Szczepanek

SM

,

McNamara

JT

,

Secor

ER

, et al.

Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease

.

Am J Pathol

.

2012

;

181

(

5

):

1725

-

1734

.

41.

Yi

W

,

Bao

W

,

Rodriguez

M

, et al.

Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease

.

Blood Adv

.

2018

;

2

(

23

):

3462

-

3478

.

42.

Tomchuck

SL

,

Norton

EB

,

Garry

RF

, et al.

Mesenchymal stem cells as a novel vaccine platform

.

Front Cell Infect Microbiol

.

2012

;

2

:

140

.

43.

Bikorimana

JP

,

Abusarah

J

,

Salame

N

,

El-Hachem

N

,

Shammaa

R

,

Rafei

M

.

Humoral immunity to allogeneic immunoproteasome-expressing mesenchymal stromal cells requires efferocytosis by endogenous phagocytes

.

Cells

.

2022

;

11

(

4

):

596

.

44.

Rosenbaum

P

,

Tchitchek

N

,

Joly

C

, et al.

Vaccine inoculation route modulates early immunity and consequently antigen-specific immune response

.

Front Immunol

.

2021

;

12

:

645210

.

45.

Mullins

DW

,

Sheasley

SL

,

Ream

RM

,

Bullock

TN

,

Fu

YX

,

Engelhard

VH

.

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

.

J Exp Med

.

2003

;

198

(

7

):

1023

-

1034

.

46.

Guinamard

R

,

Okigaki

M

,

Schlessinger

J

,

Ravetch

JV

.

Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response

.

Nat Immunol

.

2000

;

1

(

1

):

31

-

36

.

47.

Cinamon

G

,

Zachariah

MA

,

Lam

OM

,

Foss

FW

,

Cyster

JG

.

Follicular shuttling of marginal zone B cells facilitates antigen transport

.

Nat Immunol

.

2008

;

9

(

1

):

54

-

62

.

48.

Kraal

G

.

Antigens take the shuttle

.

Nat Immunol

.

2008

;

9

(

1

):

11

-

12

.

49.

Zhang

L

,

Ding

Z

,

Xu

H

,

Heyman

B

.

Marginal zone B cells transport IgG3-immune complexes to splenic follicles

.

J Immunol

.

2014

;

193

(

4

):

1681

-

1689

.

50.

Diana

J

,

Simoni

Y

,

Furio

L

, et al.

Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes

.

Nat Med

.

2013

;

19

(

1

):

65

-

73

.

51.

Deng

J

,

Wang

X

,

Chen

Q

, et al.

B1a cells play a pathogenic role in the development of autoimmune arthritis

.

Oncotarget

.

2016

;

7

(

15

):

19299

-

19311

.

52.

Peterson

LK

,

Tsunoda

I

,

Fujinami

RS

.

Role of CD5+ B-1 cells in EAE pathogenesis

.

Autoimmunity

.

2008

;

41

(

5

):

353

-

362

.

53.

Narang

A

,

Qiao

F

,

Atkinson

C

, et al.

Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury, drive secondary injury by activating complement

.

J Neuroinflammation

.

2017

;

14

(

1

):

120

.

54.

Spurrier

MA

,

Jennings-Gee

JE

,

Haas

KM

.

Type I IFN receptor signaling on B cells promotes antibody responses to polysaccharide antigens

.

J Immunol

.

2023

;

210

(

2

):

148

-

157

.

55.

Hermand

P

,

Azouzi

S

,

Gautier

EF

, et al.

The proteome of neutrophils in sickle cell disease reveals an unexpected activation of interferon alpha signaling pathway

.

Haematologica

.

2020

;

105

(

12

):

2851

-

2854

.

56.

Hounkpe

BW

,

Fiusa

MM

,

Colella

MP

, et al.

Role of innate immunity-triggered pathways in the pathogenesis of sickle cell disease: a meta-analysis of gene expression studies

.

Sci Rep

.

2015

;

5

:

17822

.

57.

Sheehan

KC

,

Lai

KS

,

Dunn

GP

, et al.

Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection

.

J Interferon Cytokine Res

.

2006

;

26

(

11

):

804

-

819

.

58.

Hwang

SY

,

Hertzog

PJ

,

Holland

KA

, et al.

A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses

.

Proc Natl Acad Sci U S A

.

1995

;

92

(

24

):

11284

-

11288

.

59.

Waffarn

EE

,

Hastey

CJ

,

Dixit

N

, et al.

Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation

.

Nat Commun

.

2015

;

6

(

1

):

8991

.

60.

Tsay

GJ

,

Zouali

M

.

The interplay between innate-like B cells and other cell types in autoimmunity

.

Front Immunol

.

2018

;

9

:

1064

.

61.

Weller

S

,

Braun

MC

,

Tan

BK

, et al.

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

.

Blood

.

2004

;

104

(

12

):

3647

-

3654

.

62.

Bautista

D

,

Vasquez

C

,

Ayala-Ramirez

P

, et al.

Differential expression of IgM and IgD discriminates two subpopulations of human circulating IgM(+)IgD(+)CD27(+) B cells that differ phenotypically, functionally, and genetically

.

Front Immunol

.

2020

;

11

:

736

.

63.

Griffin

DO

,

Rothstein

TL

.

Human B1 cell frequency: isolation and analysis of human b1 cells

.

Front Immunol

.

2012

;

3

:

122

.

64.

Quach

TD

,

Rodriguez-Zhurbenko

N

,

Hopkins

TJ

, et al.

Distinctions among circulating antibody-secreting cell populations, including B-1 cells, in human adult peripheral blood

.

J Immunol

.

2016

;

196

(

3

):

1060

-

1069

.

65.

Wu

YY

,

Georg

I

,

Diaz-Barreiro

A

, et al.

Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels

.

J Immunol

.

2015

;

194

(

12

):

5692

-

5702

.

66.

Blanco

P

,

Palucka

AK

,

Gill

M

,

Pascual

V

,

Banchereau

J

.

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus

.

Science

.

2001

;

294

(

5546

):

1540

-

1543

.

67.

Preble

OT

,

Black

RJ

,

Friedman

RM

,

Klippel

JH

,

Vilcek

J

.

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

.

Science

.

1982

;

216

(

4544

):

429

-

431

.

68.

Niewold

TB

,

Hua

J

,

Lehman

TJ

,

Harley

JB

,

Crow

MK

.

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus

.

Genes Immun

.

2007

;

8

(

6

):

492

-

502

.

69.

Psarras

A

,

Emery

P

,

Vital

EM

.

Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy

.

Rheumatology

.

2017

;

56

(

10

):

1662

-

1675

.

70.

Crow

MK

.

Advances in lupus therapeutics: achieving sustained control of the type I interferon pathway

.

Curr Opin Pharmacol

.

2022

;

67

:

102291

.

71.

Liu

Z

,

Davidson

A

.

IFNalpha inducible models of murine SLE

.

Front Immunol

.

2013

;

4

:

306

.

72.

Reeves

WH

,

Lee

PY

,

Weinstein

JS

,

Satoh

M

,

Lu

L

.

Induction of autoimmunity by pristane and other naturally occurring hydrocarbons

.

Trends Immunol

.

2009

;

30

(

9

):

455

-

464

.

73.

Zhuang

H

,

Szeto

C

,

Han

S

,

Yang

L

,

Reeves

WH

.

Animal models of interferon signature positive lupus

.

Front Immunol

.

2015

;

6

:

291

.

74.

Enghard

P

,

Humrich

JY

,

Chu

VT

, et al.

Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development

.

Eur J Immunol

.

2010

;

40

(

6

):

1809

-

1818

.

75.

Niu

H

,

Sobel

ES

,

Morel

L

.

Defective B-cell response to T-dependent immunization in lupus-prone mice

.

Eur J Immunol

.

2008

;

38

(

11

):

3028

-

3040

.

76.

Barlev

AN

,

Malkiel

S

,

Kurata-Sato

I

,

Dorjee

AL

,

Suurmond

J

,

Diamond

B

.

FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activation

.

J Clin Invest

.

2022

;

132

(

17

):

e157250

.

77.

Pearson

HA

.

Sickle cell anemia and severe infections due to encapsulated bacteria

.

J Infect Dis

.

1977

;

136

(

suppl

):

S25

-

S300

.

78.

Payne

AB

,

Link-Gelles

R

,

Azonobi

I

, et al.

Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009

.

Pediatr Infect Dis J

.

2013

;

32

(

12

):

1308

-

1312

.

79.

Westerink

MA

,

Schroeder

HW

,

Nahm

MH

.

Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination

.

Aging Dis

.

2012

;

3

(

1

):

51

-

67

.

80.

Kobayashi

M

,

Farrar

JL

,

Gierke

R

, et al.

Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the advisory committee on immunization practices - United States, 2022

.

MMWR Morb Mortal Wkly Rep

.

2022

;

71

(

4

):

109

-

117

.

81.

Kobayashi

M

,

Pilishvili

T

,

Farrar

JL

, et al.

Pneumococcal vaccine for adults aged ≥19 years: recommendations of the advisory committee on immunization practices, United States, 2023

.

MMWR Recomm Rep (Morb Mortal Wkly Rep)

.

2023

;

72

(

3

):

1

-

39

.

82.

Haas

KM

,

Blevins

MW

,

High

KP

,

Pang

B

,

Swords

WE

,

Yammani

RD

.

Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults

.

J Infect Dis

.

2014

;

209

(

1

):

87

-

97

.

83.

Swanson

CL

,

Wilson

TJ

,

Strauch

P

,

Colonna

M

,

Pelanda

R

,

Torres

RM

.

Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response

.

J Exp Med

.

2010

;

207

(

7

):

1485

-

1500

.

84.

Mqadmi

A

,

Zheng

X

,

Yazdanbakhsh

K

.

CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia

.

Blood

.

2005

;

105

(

9

):

3746

-

3748

.

85.

Barker

RN

,

Hall

AM

,

Standen

GR

,

Jones

J

,

Elson

CJ

.

Identification of T-cell epitopes on the rhesus polypeptides in autoimmune hemolytic anemia

.

Blood

.

1997

;

90

(

7

):

2701

-

2715

.

86.

Hieronimus

L

,

Huaux

F

.

B-1 cells in immunotoxicology: mechanisms underlying their response to chemicals and particles

.

Front Toxicol

.

2023

;

5

:

960861

.

87.

Murakami

M

,

Honjo

T

.

B-1 cells and autoimmunity

.

Ann N Y Acad Sci

.

1995

;

764

(

1

):

402

-

409

.

88.

Dei Zotti

F

,

Qiu

A

,

La Carpia

F

,

Moriconi

C

,

Hudson

KE

.

A new murine model of primary autoimmune hemolytic anemia (AIHA)

.

Front Immunol

.

2021

;

12

:

752330

.

89.

Floch

A

,

Viret

S

,

Malard

L

, et al.

Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion

.

Blood Adv

.

2023

;

7

(

24

):

7608

-

7620

.

90.

Chou

ST

,

Jackson

T

,

Vege

S

,

Smith-Whitley

K

,

Friedman

DF

,

Westhoff

CM

.

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors

.

Blood

.

2013

;

122

(

6

):

1062

-

1071

.

91.

Castellino

SM

,

Combs

MR

,

Zimmerman

SA

,

Issitt

PD

,

Ware

RE

.

Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance

.

Br J Haematol

.

1999

;

104

(

1

):

189

-

194

.

92.

Aygun

B

,

Padmanabhan

S

,

Paley

C

,

Chandrasekaran

V

.

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

.

Transfusion

.

2002

;

42

(

1

):

37

-

43

.

93.

Jajosky

R

,

Patel

SR

,

Wu

SC

, et al.

Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice

.

Blood

.

2023

;

141

(

21

):

2642

-

2653

.

94.

Patel

SR

,

Bennett

A

,

Girard-Pierce

K

, et al.

Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice

.

Blood Adv

.

2018

;

2

(

2

):

105

-

115

.

95.

Bao

W

,

Yu

J

,

Heck

S

,

Yazdanbakhsh

K

.

Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice

.

Blood

.

2009

;

113

(

22

):

5624

-

5627

.